Status:
COMPLETED
Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Conditions:
Cystic Fibrosis in Children
Cystic Fibrosis
Eligibility:
All Genders
14+ years
Brief Summary
Impacts of the Covid-19 epidemic and associated lockdown measures on the management, health and behaviors of cystic fibrosis patients during the 2020 epidemic
Detailed Description
The containment of the population in France is a health measure implemented in response to SARS-CoV-2 (Covid-19) infection. For cystic fibrosis, as for many chronic diseases, this disruption is twofol...
Eligibility Criteria
Inclusion
- Patient with cystic fibrosis (Southern Chlorine \> 60 mEq/L and/or presence of 2 pathogenic mutations on the CFTR gene)
- Supported in a French CRCM (Cystic fibrosis Resource and Competence Center)
- Affiliated to a social security scheme
- Non-opposition for participation in the protocol
Exclusion
- Minor patient under 14 years of age
- Computer equipment or internet connection defect
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
746 Patients enrolled
Trial Details
Trial ID
NCT04463628
Start Date
May 15 2020
End Date
March 1 2022
Last Update
August 18 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Intercommunal hospital of Créteil
Créteil, IDF, France, 94000
2
TROUSSEAU Hospital
Paris, IDF, France, 75012
3
FOCH Hospital
Suresnes, IDF, France, 92150